.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Johnson and Johnson
Merck
Deloitte
Cerilliant
Novartis
Covington
Accenture
Fish and Richardson
Federal Trade Commission

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077111

« Back to Dashboard
NDA 077111 describes BETAMETHASONE DIPROPIONATE, which is a drug marketed by Tolmar, Actavis Mid Atlantic, Taro, Fougera Pharms, Perrigo New York, Glenmark Generics, Pharmaderm, Fougera Pharms Inc, G And W Labs Inc, Teva, and Alpharma Us Pharms, and is included in thirty-five NDAs. It is available from eighteen suppliers. Additional details are available on the BETAMETHASONE DIPROPIONATE profile page.

The generic ingredient in BETAMETHASONE DIPROPIONATE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.

Summary for 077111

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 077111

Suppliers and Packaging for NDA: 077111

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
LOTION, AUGMENTED;TOPICAL 077111 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0267 0168-0267-30 30 mL in 1 BOTTLE (0168-0267-30)
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
LOTION, AUGMENTED;TOPICAL 077111 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0267 0168-0267-60 60 mL in 1 BOTTLE (0168-0267-60)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION, AUGMENTED;TOPICALStrengthEQ 0.05% BASE
Approval Date:May 21, 2007TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Queensland Health
Federal Trade Commission
US Department of Justice
Citi
US Army
Johnson and Johnson
Boehringer Ingelheim
Medtronic
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot